Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Market Commentary — 7959 total
Semiconductor stocks are drawing heavy options bets this week. MU tops ORTEX's negative-bets ranking. It's up 284% year-to-date. That rally may be attracting profit-takers via puts. SNDK sits close behind. Sandisk has…
Analysts upgraded PWR Quanta Services today, pushing the consensus target to $769.63. The electrical infrastructure giant has a $96.6 billion market cap. Grid modernisation demand continues to underpin bullish calls on…
The most eye-catching executive filing from early September comes from Cybin, the psychedelic medicine company. Two directors — Eric So and Paul Glavine — filed purchases totaling over $2.3M combined, filed on…
Short sellers are circling hard this week. BRVE (Braveheart Bio) sits at an extraordinary 352% short interest as a percentage of free float. That jumped from 191% just seven days ago — a 161 percentage-point surge. No…
U.S. equities faced their sharpest weekly ETF outflow in sight. Equity funds shed a net $46.5B over the past week. That compares to a $484B net inflow over three months. The reversal is stark. Fixed income is picking…
Today's market is defined by one word: conviction. Insiders are buying in size. Short sellers are pushing hard. And options traders are picking sides ahead of a pivotal earnings week. The result is a market full of…
Analysts are divided this week. Amgen took the hardest hit. The $221bn biotech was downgraded. The consensus shifted from four buys to five buys before the change landed — but the rating direction is now firmly down.…
Bill Gates filed disclosures on September 1–3 showing he spent over $241 million buying Republic Services shares. The trades ran from August 28 to September 2. Gates snapped up roughly 1.09 million shares across…
Short sellers turned aggressive this week. BRVE (Braveheart Bio) leads the chaos. Its SI % of free float hit 352% — up from 192% just seven days ago. That 160-point jump in a week is extraordinary. WOLF (Wolfspeed)…
MU is the week's standout name. Analysts lifted their target price and ratings remain near-unanimous buy. The stock is up 284% year-to-date. Options flow backed the bullish case. Bulls and bears both placed large…
Options markets sent mixed signals Wednesday. Bears piled into space and pharma stocks. Chips attracted bullish flows. The divergence points to a market rotating rather than retreating. Micron Technology sits at the…
Analysts delivered a mixed bag of calls Wednesday. The standout moves span biotech, payments, and memory chips. AMGN took the sharpest hit. A consensus downgrade pushed the biotech's analyst split to 5 buys against 17…
Insider filings this month show a clear split: one top executive buying with conviction while an activist fund heads for the exit. UBER President and COO Andrew MacDonald filed purchases totalling $5.3 million on…
Short sellers made big moves last week. BRVE — Braveheart Bio — saw the most extreme reading, with SI jumping to 352% of free float, up 161 points in seven days. That level reflects aggressive synthetic short…
The week's defining story is a sharp reversal in US equities. American stock ETFs shed a net $44.7B over seven days. That contrasts sharply with the 3-month picture, where US-focused funds attracted $190.6B.…
The week's biggest catalyst arrives Wednesday, when COST reports Q4 2026 results. Costco's $399 billion market cap makes it the retail bellwether of the quarter. Then on September 30, MU reports Q4 results. Micron sits…
Bullish options bets dominated semiconductor names this week. Meta Platforms and Micron Technology topped the ORTEX positive-bets ranking over the past seven days. Advanced Micro Devices also drew heavy call flow. Its…
This week brings several confirmed earnings releases. The biggest event comes on Wednesday, September 24, when COST reports Q4 2026 results after the close. Costco's $399 billion market cap makes it one of the…
Rosenblatt Securities initiated coverage of LITE with a Buy rating today. The broker set a $1,300 target price. That implies significant upside for the photonics and optical networking company. Lumentum carries a…
Activist fund Corvex Management filed disclosures this month showing it sold over $57 million worth of ILMN shares between September 2 and 4. The filings also reveal Corvex principal Keith Meister personally sold a…
